Doxa AB (SE:DOXA)
:DOXA
Want to see SE:DOXA full AI Analyst Report?
DOXA Stock Chart & Stats
kr0.44
-kr0.01(-2.66%)
At close: 4:00 PM EST
kr0.44
-kr0.01(-2.66%)
Day’s Range― - ―
52-Week Rangekr0.35 - kr0.58
Previous CloseN/A
Volume288.05K
Average Volume (3M)738.50K
Market Cap
kr572.70M
Enterprise Valuekr1.93B
Total Cash (Recent Filing)kr57.50M
Total Debt (Recent Filing)kr1.41B
Price to Earnings (P/E)―
Beta0.43
Next Earnings
Jul 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.25
Shares Outstanding1,285,530,600
10 Day Avg. Volume416,677
30 Day Avg. Volume738,495
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.29
Price to Sales (P/S)8.91
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthHigh TTM revenue growth (+27.7%) indicates durable demand and successful commercial traction in the core market. Over a 2–6 month horizon this supports scale economics, larger addressable market share, and provides a revenue base management can leverage to fund R&D and margin improvement initiatives.
Improving Cash GenerationMaterial improvement in operating cash flow and positive free cash flow show the business can convert sales into liquidity. This strengthens solvency, funds operations or targeted investment without immediate reliance on equity raises, and reduces short-term financing pressure while management pursues profitability.
Manageable Leverage LevelLeverage around 0.69 indicates the balance sheet carries debt but retains equity capacity. This level supports access to capital for growth or working capital needs while leaving room for deleveraging as cash flow strengthens, preserving strategic flexibility versus highly leveraged peers.
Bears Say
Large Ongoing LossesSubstantial and persistent net losses undermine return generation and equity value. Large negative margins make the growth story contingent on material margin recovery; without sustained profit improvement, cash reserves and investor support could be strained over the medium term.
Volatile ProfitabilityMulti-year swings between profit and deep losses signal unstable business economics or episodic costs. Such volatility reduces predictability for capital allocation, complicates long-term planning, and raises execution risk for strategies that depend on consistent margin expansion.
Rising Balance-Sheet RiskA marked increase in leverage in recent years elevates refinancing and interest-rate exposure. If cash generation proves inconsistent, higher indebtedness could constrain investments, increase funding costs, and limit the company’s ability to respond to strategic opportunities or adverse shocks.
DOXA FAQ
What was Doxa AB’s price range in the past 12 months?
Doxa AB lowest stock price was kr0.35 and its highest was kr0.58 in the past 12 months.
What is Doxa AB’s market cap?
Doxa AB’s market cap is kr572.70M.
When is Doxa AB’s upcoming earnings report date?
Doxa AB’s upcoming earnings report date is Jul 14, 2026 which is in 50 days.
How were Doxa AB’s earnings last quarter?
Doxa AB released its earnings results on Apr 21, 2026. The company reported -kr0.016 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.016.
Is Doxa AB overvalued?
According to Wall Street analysts Doxa AB’s price is currently Overvalued.
Does Doxa AB pay dividends?
Doxa AB does not currently pay dividends.
What is Doxa AB’s EPS estimate?
Doxa AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Doxa AB have?
Doxa AB has 1,285,530,600 shares outstanding.
What happened to Doxa AB’s price movement after its last earnings report?
Doxa AB reported an EPS of -kr0.016 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.529%.
Which hedge fund is a major shareholder of Doxa AB?
Currently, no hedge funds are holding shares in SE:DOXA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Doxa AB
Doxa AB (publ), a dental company, develops, manufactures, and commercializes bioceramic dental products under the Ceramir brand worldwide. It offers Crown & Bridge, a dental cement that is used for permanent cementing of crowns and bridges. The company was founded in 1987 and is based in Uppsala, Sweden.